FixNix raises $500,000 in pre-Series A funding
The US-headquarted and Chennai-based FixNix Inc, a software as a Service (SaaS)-based governance, risk and compliance (GRC) platform for enterprises, has secured $500,000 in a pre-Series A round of funding led by Tesla Chief Information Officer Jay Vijayan and four other investors from Singapore, San Francisco.
The company is looking for raising another $1 million in the pre Series A and around $5 million in Series A funding in future. The Series A funding would be from Singapore-based investor Temasek and others.
Part of the proceeds for the pre-series A came from equity crowd-funding to finish the development of their GRC analytics, said FixNix in its announcement. The fund will also be used to strengthen its GRC team, adding 36 engineers to its existing 15 engineers and the addition would be happening in Chennai, said Shanmugavel Sankaran, CEO of FixNix.Inc.
The company has plans to move its core operations to chennai from it’s current base to be with the rest of the SaaS industry friends like Zoho, Freshdesk. By 2016 the company is planning to raise its Series A funding after validating a few new markets. "Temasek has expressed interest as there was a referral from end user entities from Singapore Govt. The company is planning for additional products in the future like GRC analytics," it said.
The company is in talks to raise the next $1 million through private placements and strategic investors like a US bank, to launch the analytics , SaaS GRC to all markets that is going to change the GRC market. The company has so far raised around $1,00,000 and it was bootstrapped with $2,50,000 including debt mortgage and support from State and Central government. It was a conscious bootstrap route in the lines of its mentor Zoho founder Sridhar Vembu for validating the problem well enough. This pre-series A was done at 13.5M valuation.
FixNix with 1,500 users, got rewarded with $ 100,000 angel cheque from a silicon valley security product company as part of Nasscom Innotrek trip incubation in silicon valley.